免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

自动胰岛素剂量设备系统,单一激素控制

PMA编号:P160017 · 2026-08-05

决定日期2026-08-05
PMA 编号P160017
产品代码OZP
设备分类第3类
医疗专科U
咨询委员会CH 请注意,您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。

器械摘要

Automated insulin dosing device system, single hormonal control is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Minimed, Inc.. It received FDA 510(k) clearance on 2026-08-05. The device is classified under product code OZP. It was reviewed by the CH advisory panel.

常见问题

What is the Automated insulin dosing device system, single hormonal control?

Automated insulin dosing device system, single hormonal control is a medical device that received FDA 510(k) clearance on 2026-08-05. The listed applicant is Medtronic Minimed, Inc..

When did Automated insulin dosing device system, single hormonal control receive FDA 510(k) clearance?

The clearance date for Automated insulin dosing device system, single hormonal control can be found in the official FDA records.

谁是自动胰岛素剂量设备系统的单激素控制列表申请人?

The FDA 510(k) record lists Medtronic Minimed, Inc. as the applicant. This does not by itself establish the device manufacturer.

什么是自动胰岛素剂量设备系统的FDA产品代码,单一激素控制?

FDA产品代码为自动胰岛素剂量设备系统的单激素控制是OZP。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑